Journals / Kafkas Üniversitesi Veteriner Fakültesi Dergisi / 2020 / Cilt: 26 - Sayı: 1

Gossypin Protects Against Renal Ischemia- Reperfusion Injury in Rats

Gossypin Sıçanlarda Böbrek İskemi- Reperfüzyon Hasarına Karşı Korur

Pages
89–96
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Therewas a statistically signifiant decrease in IL-1β and IL-6 levels of the gossypin groups compared to the I/R group (P

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Renal injury occurring as a result of renal ischemia-reperfusion may lead to renal failure or even death.
📊
Key Findings & Data:A total of 48 male Wistaralbino rats were used in the study.
💡
Conclusion & Impact:Therewas a statistically signifiant decrease in IL-1β and IL-6 levels of the gossypin groups compared to the I/R group (P
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Renal injury occurring as a result of renal ischemia-reperfusion may lead to renal failure or even death. The aim of this study is to investigatepossible protective effcts of Gossypin on tissue damage occurred due to ischemia-reperfusion in rat kidney tissue. A total of 48 male Wistaralbino rats were used in the study. These rats were randomly divided into 6 groups equally (n = 8). The created groups were control (C),sham (S), ischemia-reperfusion (I/R), I/R + DMSO, I/R + 400 μg/kg gossypin and I/R + 4 mg/kg gossypin. In the rats of sham group, the rightnephrectomy was performed. In the rats of other groups rather than sham, the left renal artery was clamped after performing the rightnephrectomy. Gossypin was administered intraperitoneally before the reperfusion. 24 h reperfusion was applied to the left renal after 1 hof ischemia. TNF-α, IL-1β, IL-6 and IL-10 levels were measured with spectrophotometric methods in the kidney tissues after the procedureswere completed. Apoptosis and inflmmatory pathways were evaluated histopathologically using Caspase 3 and NF-κB antibodies. Therewas a statistically signifiant decrease in IL-1β and IL-6 levels of the gossypin groups compared to the I/R group (P

Özet

Böbrek iskemi reperfüzyonu sonucu meydana gelen renal hasar, böbrek yetmezliğine ve hatta ölüme neden olabilir. Çalışmanın amacı sıçan böbrek dokusunda iskemi-reperfüzyona bağlı oluşan doku hasarına karşı gossypinin olası koruyucu etkilerini araştırmaktır. Çalışmada toplam 48 adet Wistar albino cinsi erkek sıçan kullanıldı. Sıçanlar randomize ve eşit olmak üzere 6 gruba ayrıldı (n=8). Kontrol (C), sham (S), istemi-reperfüzyon (I/R), I/R + DMSO, I/R + 400 μg/kg gossypin ve I/R + 4 mg/kg gossypin grupları oluşturuldu. Sham grubunda arka bölge açılarak sağ nefrektomi yapıldı. Gossypin reperfüzyondan önce intraperitoneal olarak uygulandı. Sol renal artere 1 saat iskemi sonunda 24 saat reperfüzyon uygulandı. Prosedürler tamamlandıktan sonra böbrek dokularında spektrofotometrik metodlarla TNF-α, IL- 1β, IL-6 and IL-10 seviyeleri ölçüldü. Apoptozis ve inflmatuvar yolaklar kazpaz-3 ve NF-κB antikorları kullanılarak değerlendirildi. Gossypin grupları I/R grupları ile kıyaslanınca IL-1β and IL-6 seviyelerinde istatistiksel olarak önemli derecede azalma tespit edildi (P

🔖

Cite This Article

ERASLAN, E., TANYELİ, A., GÜLER, M. C., AKARAS, N., KURT, N. (2022). Gossypin Protects Against Renal Ischemia- Reperfusion Injury in Rats. Kafkas Üniversitesi Veteriner Fakültesi Dergisi, Cilt: 26 - Sayı: 1, 89–96. https://ajindex.com/articles/569585

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Dominguez JH, Liu Y, Gao H, Dominguez JM, Xie D, Kelly KJ: Renal tubular cell-derived extracellular vesicles accelerate the recovery of established renal ıschemia reperfusion ınjury. J Am Soc Nephrol, 28 (12): 3533-3544, 2017. DOI: 10.1681/asn.2016121278 2. Ahmadiasl N, Banaei S, Alihemmati A, Baradaran B, Azimian E: The anti-inf ammatory ef ect of erythropoietin and melatonin on renal ischemia reperfusion injury in male rats. Adv Pharm Bull, 4 (1): 49-54, 2014. DOI: 10.5681/apb.2014.008 3. Sancaktutar AA, Bodakci MN, Hatipoglu NK, Soylemez H, Basarili K, Turkcu G: The protective ef ects of pomegranate extracts against renal ischemia-reperfusion injury in male rats. Urol Ann, 6 (1): 46-50, 2014. DOI: 10.4103/0974-7796.127029 4. Yun Y, Duan WG, Chen P, Wu HX, Shen ZQ, Qian ZY, Wang DH: Ischemic postconditioning modified renal oxidative stress and lipid peroxidation caused by ischemic reperfusion injury in rats. Transplant Proc, 41 (9): 3597-3602, 2009. DOI: 10.1016/j.transproceed.2009.06.203 5. Fadillioglu E, Kurcer Z, Parlakpinar H, Iraz M, Gursul C: Melatonin treatment against remote organ injury induced by renal ischemia reperfusion injury in diabetes mellitus. Arch Pharm Res, 31 (6): 705-712, 2008. DOI: 10.1007/s12272-001-1216-3 6. Miranda LE, Capellini VK, Reis GS, Celotto AC, Carlotti CG Jr, Evora PR: Ef ects of partial liver ischemia followed by global liver reperfusion on the remote tissue expression of nitric oxide synthase: Lungs and kidneys. Transplant Proc, 42 (5): 1557-1562, 2010. DOI: 10.1016/j. transproceed.2010.02.097 7. Yahfoufi N, Alsadi N, Jambi M, Matar C: The immunomodulatory and anti-inf ammatory role of polyphenols. Nutrients, 10 (11): pii: E1618, 2018. DOI: 10.3390/nu10111618 8. Bisht S, Dada R: Oxidative stress: Major executioner in disease pathology, role in sperm DNA damage and preventive strategies. Front Biosci (Schol Ed), 9, 420-447, 2017. DOI: 10.2741/s495 9. Kim J, Jang HS, Park KM: Reactive oxygen species generated by renal ischemia and reperfusion trigger protection against subsequent renal ischemia and reperfusion injury in mice. Am J Physiol Renal Physiol, 298 (1): F158-F166, 2010. DOI: 10.1152/ajprenal.00474.2009 10. Sengul O, Ferah I, Polat B, Halici Z, Bayir Y, Yilmaz M, Kilic N, Keles ON: Blockade of endothelin receptors with bosentan limits ischaemia/ reperfusion-induced injury in rat ovaries. Eur J Obstet Gynecol Reprod Biol, 170 (2): 458-463, 2013. DOI: 10.1016/j.ejogrb.2013.06.040 11. Zhai Y, Behera J, Tyagi SC